These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1417069)

  • 21. Treatment of PUVA- and retinoid-PUVA-resistant severe psoriasis with systemic cyclosporin A.
    Takashima A; Morita A; Tsuji T
    J Dermatol; 1990 Aug; 17(8):482-8. PubMed ID: 2229652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Etretinate on the neutrophil chemotaxis in pustular psoriasis.
    Pigatto PD; Brugo AM; Finzi AF
    Boll Ist Sieroter Milan; 1982 May; 61(2):112-5. PubMed ID: 7126334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A; Martín M; Geiger JM; Marrón JM
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010.
    Akasaka E; Mabuchi T; Manabe Y; Yahagi E; Yamada-Hiruma A; Yamaoka H; Kojima T; Kato M; Ikoma N; Ozawa A; Haruki Y
    J Dermatol; 2013 Apr; 40(4):238-43. PubMed ID: 23330814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis.
    Brechtel B; Wellenreuther U; Toppe E; Czarnetzki BM
    J Am Acad Dermatol; 1994 Jun; 30(6):1023-4. PubMed ID: 8188867
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination-therapy cyclosporin-A--etretinate for psoriasis.
    Korstanje MJ; van de Staak WJ
    Clin Exp Dermatol; 1990 May; 15(3):172-3. PubMed ID: 2364569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased urinary polyamines in patients with psoriasis treated with etretinate.
    Grekin RC; Ellis CN; Goldstein NG; Swanson NA; Anderson TF; Duell EA; Voorhees JJ
    J Invest Dermatol; 1983 Mar; 80(3):181-4. PubMed ID: 6827127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Fc-receptor defect of polymorphonuclear leukocytes in a patient with Sjögren's syndrome.
    Schopf RE; Rehder M; Laux B; Korting GW
    Klin Wochenschr; 1987 Apr; 65(7):342-4. PubMed ID: 3586572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of etretinate on cyclosporin metabolism in vitro.
    Webber IR; Back DJ
    Br J Dermatol; 1993 Jan; 128(1):42-4. PubMed ID: 8427820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
    Lauharanta J; Geiger JM
    Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive oxygen species production in circulating polymorphonuclear leukocytes in psoriasis.
    De Simone C; De Sole P; Di Mario G; Venier A; Cerimele D; Serri F
    Acta Derm Venereol Suppl (Stockh); 1989; 146():50-2. PubMed ID: 2609883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of bioactive glasses on the respiratory burst metabolism of polymorphonuclear neutrophils].
    Maitz MF; Gabriel E; Franke RP
    Biomed Tech (Berl); 1999 Jun; 44(6):172-5. PubMed ID: 10427913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis--measurement of lucigenin-dependent chemiluminescence.
    Kapp A; Schöpf E
    Acta Derm Venereol; 1986; 66(4):285-9. PubMed ID: 2430396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gold complexes and activation of human polymorphonuclear leukocytes. Dissociation of changes in membrane potential and oxidative burst.
    Rudkowski R; Ziegler JB; Graham GG; Joulianos G
    Biochem Pharmacol; 1992 Sep; 44(6):1091-8. PubMed ID: 1417933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of etretinate on chemotaxis of neutrophils from patients with pustular and vulgar psoriasis.
    Pigatto PD; Riva F; Altomare GF; Brugo AM; Morandotti A; Finzi AF
    J Invest Dermatol; 1983 Nov; 81(5):418-9. PubMed ID: 6631053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose cyclosporin A in severe psoriasis. A double-blind study.
    Van Joost T; Bos JD; Heule F; Meinardi MM
    Br J Dermatol; 1988 Feb; 118(2):183-90. PubMed ID: 3280000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of butylated hydroxyanisole and some of its derivatives on human neutrophil oxidative burst: chemiluminescence evaluation.
    Braga PC; dal Sasso M; Bovio C; Sgaragli GP
    Pharmacology; 2003 May; 68(1):9-16. PubMed ID: 12660474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses.
    Kaplan RP; Russell DH; Lowe NJ
    J Am Acad Dermatol; 1983 Jan; 8(1):95-102. PubMed ID: 6826812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired function of numerically augmented Fc-receptors on granulocytes in a HLA B8+ patient with palmoplantar pustulosis.
    Schopf RE; Rehder M; Benes P; Bork K; Morsches B
    Arch Dermatol Res; 1987; 279(7):444-8. PubMed ID: 3435172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.